Kexing Biopharm Co., Ltd.

¥15.53As of Sun 8 Nov 2026, 12:00 UTC
SSE:688136Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (14.93%)
Div yield 1.61%
ROE 3.91%
Biotechnology
Beta (5Y) 0.58
PE TTM 43.75
TSR TTM (61.90%)
Mkt cap ¥3.084B
ROIC (5.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥17
11.95%
494.89%
Hold 7|10|11|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.31
0.33
0.33
0.36
13.76%
14.98%
10.99%
27.70%
Revenue¥M
233.5
244.8
249.2
263.5
4.63%
9.06%
8.60%
10.32%
Peers (US$462.3M)
Cap (US$)
PE
475.3M
—
462.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.909
0.973
0.813
EBIT/Intx
1.183
1.037
0.733
Own earn%
(19.55)
79.01
73.04
Sh yield%
40.40
12.25
16.41
Owners
Insiders/Inst%
1.26
76.43
Short interest%
0.69
SBC / revenue%
4.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–9
$1 testx
0.0
Incr. ROIC%
27